E-Z-EM’s wholly owned subsidiary AngioDynamics has filed a registration statement with the Securities and Exchange Commission (SEC) for an initial public offering (IPO) of common stock.
RBC Capital Markets will act as lead manager and sole book-running manager, with Adams Harkness and Hill serving as co-manager, according to Queensbury, NY-based AngioDynamics. The company’s application is for a listing on the Nasdaq National Market under the symbol “ANGO.”
By AuntMinnie.com staff writers
March 8, 2004
E-Z-EM continues strong growth in 2004 Q2, January 9, 2004
E-Z-EM, SourceOne to study barium cost reduction, August 28, 2003
E-Z-EM notches record 2003, August 13, 2003
E-Z-EM, Berlex to partner, July 15, 2003
E-Z-EM to close New York and Puerto Rico operations, June 2, 2003
Copyright © 2004 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
